Rb functions to inhibit apoptosis during myocyte differentiation

Cancer Research

Volumn 57, Issue 3, 1997, Pages 351-354

  Wang, Jian ^a   Guo, Kun ^a   Wills, Kenneth N ^b   Walsh, Kenneth ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P16; PROTEIN P21; RETINOBLASTOMA PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL SURVIVAL; ETIOLOGY; INHIBITION KINETICS; MOUSE; MUSCLE CELL; MUSCLE DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RECEPTOR UPREGULATION;

ANIMALS; APOPTOSIS; CARRIER PROTEINS; CELL DIFFERENTIATION; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASES; CYCLINS; MICE; MUSCLE, SKELETAL; RETINOBLASTOMA PROTEIN;

EID: 0031050236     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Wang, J., and Walsh, K. Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation. Science (Washington DC), 273: 359-361, 1996.
2. Andrés, V., and Walsh, K. Myogenin expression, cell cycle withdrawal and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis. J. Cell Biol., 132: 657-666, 1996.
3. Wang, J., and Walsh, K. Inhibition of retinoblastoma protein phosphorylation by myogenesis-induced changes in the subunit composition of the cyclin dependent kinase 4 complex. Cell Growth & Differ., 7: 1471-1478, 1996.
4. Weinberg, R. A. The retinoblastoma protein and cell cycle control. Cell, 81: 323-330, 1995.
5. Gu, W., Schneider, J. W., Condorelli, G., and Nadal-Ginard, B. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell, 72: 309-324, 1993.
6. Martelli, F., Cenciarelli, C., Santarelli, G., Polikar, B., Felsani, A., and Caruso, M. MyoD induces retinoblastoma gene expression during myogenic differentiation. Oncogene, 9: 3579-3590, 1994.
7. cdc2 expression during terminal differentiation of C2C12 myocytes. Biochem. Biophys. Res. Commun., 206: 82-88, 1995.
8. Guo, K., Wang, J., Andres, V., Smith, R. C., and Walsh, K. MyoD-induced expression of p21 inhibits cydin-dependent kinase activity upon myocyte terminal differentiation. Mol. Cell. Biol, 15: 3823-3829, 1995.
9. Schneider, J. W., Gu, W., Zhu, L., Mahdavi, V., and Nadal-Ginard, B. Reversal of terminal differentiation mediated by p107 in Rb-/- muscle cells. Science (Washington DC), 264: 1467-1471, 1994.
10. Wills, K. N., Maneval, D. C., Menzel, P., Harris, M. P., Sutjipto, S., Vaillancourt, M. T., Huang, W. M., Johnson, D. E., Andersen, S. C., Wen, S. F., Bookstein, R., Shepard, H. M., and Gregory, R. J. Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer. Hum. Gene Ther., 5: 1079-1088, 1994.
11. Wills, K. N., Huang, W. M., Harris, M. P., Machemar, T., Maneval, D. C., and Gregory, R. J. Gene therapy for hepatocellular carcinoma: chemosensitivity conferred by adenovirus-mediated transfer of the HSV-1 thymidine kinase gene. Cancer Gene Ther., 2: 191-197, 1995.
12. Hemstrom, C., Nordqvist, K., Pettersson, U., and Virtanen, A. Gene product of region E4 of adenovirus type 5 modulates accumulation of certain viral polypeptides. J. Virol., 62: 3258-3264, 1988.
13. Huyghe, B. G., Liu, X., Sutjipto, S., Sugarman, B. J., Horn, M. T., Shepard, H. M., Scandella, C. J., and Shabram, P. Purification of a Type 5 recombinant adenovirus encoding human p53 by column Chromatography. Hum. Gene Ther., 6: 1403-1416, 1995.
14. Ormerod, M. G., Collins, M. K. L., Rodriguez-Tarduchy, G., and Robertson, D. Apoptosis in interleukin-3 dependent haemopoietic cells: quantification by flow cytometric methods. J. Immunol. Methods, 153: 57-65, 1992.
15. Kranenburg, O., van der Eb, A. J., and Zantema, A. Cyclin D1 is an essential mediator of apoptotic neuronal cell death. EMBO J., 15: 46-54, 1996.
16. WAF1 is required for survival of differentiating neuroblastoma cells. Mol. Cell Biol., 16: 1335-1341, 1996.
17. Jiang, H. P., Lin, J., Su, Z. Z., Collart, F. R., Huberman, E., and Fisher, P. B. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/Cip1 expression in absence of p53. Oncogene, 9: 3397-3406, 1994.
18. Xu, H-M., Tepper, C. G., Jones, J. B., Fernandez, C. E., and Studzinski, G. P. 1,25-Dihydroxyvitamin D3 protects HL60 cells against apoptosis but down-regulates the expression of the bcl-2 gene. Exp. Cell Res., 209: 367-374, 1993.
19. 3in HL60 cells. Cancer Res., 56: 264-267, 1996.
20. Haas-Kogan, D. A., Kogan, S. C., Levi, D., Dazin, P., T'ang, A., Fung, Y-K. T., and Israel, M. A. Inhibition of apoptosis by the retinoblastoma gene product. EMBO J., 14: 461-472, 1995.
21. Haupt, Y., Rowan, S., and Oren, M. p53-mediated apoptosis in HeLa cells can be overcome by excess pRB. Oncogene, 10: 1563-1571, 1995.
22. Kirshenbaum, L. A., and Schneider, M. D. Adenovirus E1A represses cardiac gene transcription and reactives DNA synthesis in ventricular myocytes. via alternative pocket protein- and p300-binding domains. J. Biol. Chem., 14: 7791-7794, 1995.
23. Liu, Y., and Kitsis, R. N. Induction of DNA synthesis and apoptosis in cardiac myocytes by E1A oncoprotein. J. Cell Biol., 133: 325-334, 1996.
24. Qin, X-Q., Livingston, D., Kaelin, W. G., and Adams, P. D. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. USA, 91: 10918-10922, 1994.
25. Shan, B., and Lee, W-H. Deregulated expression of E2F1 induces S-phase entry and leads to apoptosis. Mol. Cell. Biol., 14: 8166-8172, 1994.
26. Wu, X., and Levine, A. L. p53 and E2F1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. USA, 91: 3602-3606, 1994.